BIOHIT HealthCare recently hosted a fascinating webinar on Peptest, its innovative, non-invasive saliva-based test that is redefining reflux diagnosis. Led by Andrew Woodcock, Chief Scientific Officer at RD Biomed, the comprehensive session explored the science behind Peptest, from its early development using lateral flow technology to its validation in multicentre clinical studies.
Peptest detects pepsin in samples from the upper digestive and respiratory tracts, offering a faster, more patient-friendly alternative to traditional diagnostics. The webinar, entitled Reimagining reflux diagnosis, showcased how this tool supports timely, accurate decision-making across the ENT, gastroenterology, and speech and language therapy fields, especially for patients presenting with non-specific symptoms.
If you missed this informative session, you can still benefit from the insights shared! Watch the webinar on demand now and discover how Peptest is shaping the future of reflux management.
